02192 MEDLIVE
- 8.250
- +0.100+1.23%
MEDLIVE News
醫脈通：年報2023
Medlive Technology Co., Ltd. (HKG:2192) Full-Year Results: Here's What Analysts Are Forecasting For This Year
As you might know, Medlive Technology Co., Ltd. (HKG:2192) recently reported its full-year numbers. The result was positive overall - although revenues of CN¥412m were in line with what the anal
MEDLIVE To Go Ex-Dividend On May 28th, 2024 With 0.1375 HKD Dividend Per Share
March 26th - $MEDLIVE(02192.HK)$ is trading ex-dividend on May 28th, 2024. Shareholders of record on May 29th, 2024 will receive 0.1375 HKD dividend per share on June 24th, 2024. The ex-dividend d
Medical Pulse (02192) will pay a final dividend of $0.1248 per share on June 24
Medical Pulse (02192) announced that the company will distribute it on June 24, 2024 until 2024 until 2023...
Yimaitong (02192.HK)'s annual adjusted net profit of about 271 million yuan increased by about 86.8% year-on-year
Gelonghui (02192.HK) announced on March 25, that for the year ended December 31, 2023, the Group's revenue was approximately RMB 412.0 million, an increase of 31.2% over the same period last year. While expanding revenue, the Group continued to increase its profitability. The Group's net profit increased from RMB 126.4 million for the year ended December 31, 2022 to RMB 251.8 million for the year ended December 31, 2023, an increase of 99.1% over the previous year. Net profit margin increased by approximately 40.3% for the year ended December 31, 2022
MEDLIVE: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Medical Communications (02192.HK) plans to hold a board meeting on March 25 to approve the annual results
Gelonghui March 13 | Medical Communications (02192.HK) announced that the company will hold a board meeting on March 25, 2024 (Monday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider paying a final dividend (if any).
MEDLIVE: DATE OF BOARD MEETING
Medlive Technology to Double Profit in 2023
Medlive Technology (HKG:2192) expects its attributable profit for the year ended Dec. 31, 2023, to rise to at least 235 million yuan from 117.3 million yuan a year earlier, the online physician platfo
Medical Pulse (02192.HK) Yingxi: Net profit due to mother is expected to increase to no less than 235 million yuan in fiscal year 2023
On February 28, GLONGHUI (02192.HK) announced that for the year ended December 31, 2023 (“Fiscal Year 2023"), the board of directors expects revenue for fiscal year 2023 to increase from RMB 314 million to no less than RMB 410 million for the year ended December 31, 2022; profit attributable to owners of parent companies recorded a significant increase, increasing to no less than RMB 235 million from the profit attributable to owners of parent companies for the year ended December 31, 2022.
MEDLIVE: POSITIVE PROFIT ALERT
Medlive Technology Co., Ltd.'s (HKG:2192) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 28% over the past three months, it is easy to disregard Medlive Technology (HKG:2192). But if you pay close attention, you might find that its key financial indicators look quite
Medlive Technology (HKG:2192) Will Be Hoping To Turn Its Returns On Capital Around
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Ideally, a business will show two trends; firstly a growing return on capital emp
Yimaitong (02192) cancelled the repurchased shares of 100,000 shares on December 20
Yimaitong (02192) issued an announcement to cancel the repurchased shares of 100,000 shares on December 20, 2023.
Is Medlive Technology Co., Ltd. (HKG:2192) Expensive For A Reason? A Look At Its Intrinsic Value
Key Insights Using the 2 Stage Free Cash Flow to Equity, Medlive Technology fair value estimate is HK$6.61 Current share price of HK$8.54 suggests Medlive Technology is potentially 29% overvalued
Medlive Technology Co., Ltd.'s (HKG:2192) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Medlive Technology (HKG:2192) has had a great run on the share market with its stock up by a significant 27% over the last three months. As most would know, fundamentals are what usually guide marke
Medical Connect (02192.HK) plans to acquire 60% of the shares in Lingbo Market Information Consulting (Shanghai) for RMB 33.93 million
GLONGHUI, Oct. 12 (02192.HK) announced that on October 12, 2023, Jinye Tiancheng Beijing, the seller (Wu Ning, Chen Lifei, Gao Yifan) and the target company Ling Bo Market Information Consulting (Shanghai) Co., Ltd. signed a share transfer agreement. According to this, Seller A, Seller B, and Seller C respectively agreed to sell 42%, 9%, and 9% of the shares of the target company, while Jinye Tiancheng Beijing agreed to buy 60% of the shares of the target company at a cost of RMB 33.93 million.. The target company is mainly engaged in the business of providing research services to pharmaceutical companies. It has
Additional Considerations Required While Assessing Medlive Technology's (HKG:2192) Strong Earnings
Medlive Technology Co., Ltd.'s (HKG:2192) robust earnings report didn't manage to move the market for its stock. Our analysis suggests that shareholders have noticed something concerning in the numbe
Medlive Technology Insider Lowered Holding By 58% During Last Year
Viewing insider transactions for Medlive Technology Co., Ltd.'s (HKG:2192 ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders i
Medical Connect (02192.HK) received FIL Limited's holdings increased by 485,500 shares
GLONGHUI, September 26 | According to the latest equity disclosure information from the Stock Exchange, on September 20, 2023, Medical Connect (02192.HK) received FIL Limited's holdings on the market to increase its holdings by 485,500 shares at an average price of HK$7.4669 per share, involving approximately HK$3,6252 million. After the increase in holdings, the latest number of shares held by FIL Limited was 656.674 million shares, and the shareholding ratio increased from 8.97% to 9.03%.
Analysis
Price Target
No Data
